Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis

Osteoarthritis and Cartilage

Volumn 17, Issue 3, 2009, Pages 375-383

  Vinardell, T ^a   Dejica, V ^b   Poole, A R ^c   Mort, J S ^b,c   Richard, H ^a   Laverty, S ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Cartilage; Cathepsin K; Horse; Osteoarthritis; Type II collagen

Indexed keywords

CATHEPSIN K; COLLAGENASE; COLLAGENASE 3; EPITOPE; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; PROTEIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; HISTOPATHOLOGY; HORSE; IMMUNOHISTOCHEMISTRY; MALE; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; CARPUS, ANIMAL; CARTILAGE, ARTICULAR; CATHEPSINS; COLLAGEN TYPE II; COLLAGENASES; EPITOPES; FEMALE; HORSE DISEASES; HORSES; MALE; OSTEOARTHRITIS; STAINING AND LABELING;

EID: 60249099358     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.07.017     Document Type: Article

References (37)

1. Poole A.R., Kobayashi M., Yasuda T., Laverty S., Mwale F., Kojima T., et al. Type II collagen degradation and its regulation in articular cartilage in osteoarthritis. Ann Rheum Dis 61 Suppl 2 (2002) ii78-ii81
2. Pelletier J.P., Boileau C., Boily M., Brunet J., Mineau F., Geng C., et al. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Res Ther 7 (2005) R1091-R1102
3. Poole A.R., Kojima T., Yasuda T., Mwale F., Kobayashi M., and Laverty S. Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res (2001) S26-S33
4. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter P. Cell junctions, cell adhesion and the extracellular matrix. In: Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter P. (Eds). Molecular biology of the cell (2002), GS, New York 1065-1125
5. Bluteau G., Conrozier T., Mathieu P., Vignon E., Herbage D., and Mallein-Gerin F. Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 1526 (2001) 147-158
6. Hou W.S., Li W., Keyszer G., Weber E., Levy R., Klein M.J., et al. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum 46 (2002) 663-674
7. Dejica V.M., Mort J.S., Laverty S., Percival M.D., Antoniou J., Zukor D.J., et al. Cleavage of Type II Collagen by Cathepsin K in Human Osteoarthritic Cartilage. Am J Pathol (2008)
8. Moreau M., Boileau C., Martel-Pelletier J., Brunet J., Laufer S., and Pelletier J.P. Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activity. J Rheumatol 33 (2006) 1176-1183
9. Kafienah W., Bromme D., Buttle D.J., Croucher L.J., and Hollander A.P. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 331 Pt 3 (1998) 727-732
10. Li Z., Yasuda Y., Li W., Bogyo M., Katz N., Gordon R.E., et al. Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J Biol Chem 279 (2004) 5470-5479
11. Morko J.P., Soderstrom M., Saamanen A.M., Salminen H.J., and Vuorio E.I. Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis. Ann Rheum Dis 63 (2004) 649-655
12. Morko J., Kiviranta R., Joronen K., Saamanen A.M., Vuorio E., and Salminen-Mankonen H. Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K. Arthritis Rheum 52 (2005) 3713-3717
13. Martin TM. Guide for Determining the Age of the Horse. 6 Edition., American Association of Equine Practioners 2006.
14. Mankin H.J., Dorfman H., Lippiello L., and Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. The Journal of Bone And Joint Surgery 53 (1971) 523-537
15. Dayan D., Hiss Y., Hirshberg A., Bubis J.J., and Wolman M. Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers?. Histochemistry 93 (1989) 27-29
16. Hughes L.C., Archer C.W., and ap Gwynn I. The ultrastructure of mouse articular cartilage: collagen orientation and implications for tissue functionality. A polarised light and scanning electron microscope study and review. Eur Cell Mater 9 (2005) 68-84
17. Richardson D.W., and Dodge G.R. Cloning of equine type II procollagen and the modulation of its expression in cultured equine articular chondrocytes. Matrix Biol 16 (1997) 59-64
18. Anway M.D., Wright W.W., Zirkin B.R., Korah N., Mort J.S., and Hermo L. Expression and localization of cathepsin k in adult rat sertoli cells. Biol Reprod 70 (2004) 562-569
19. Mort J.S., and Roughley P.J. Production of antibodies against degradative neoepitopes in aggrecan. Methods Mol Med 100 (2004) 237-250
20. Poole A.R., Ionescu M., Fitzcharles M.A., and Billinghurst R.C. The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. J Immunol Methods 294 (2004) 145-153
21. Hollander A.P., Heathfield T.F., Webber C., Iwata Y., Bourne R., Rorabeck C., et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 93 (1994) 1722-1732
22. Laverty S., Okouneff S., Ionescu M., Reiner A., Pidoux I., Webber C., et al. Excessive degradation of type II collagen in articular cartilage in equine osteochondrosis. J Orthop Res 20 (2002) 1282-1289
23. Fradette M.E., Celeste C., Richard H., Beauchamp G., and Laverty S. Effects of continuous oral administration of phenylbutazone on biomarkers of cartilage and bone metabolism in horses. Am J Vet Res 68 (2007) 128-133
24. Donabedian M., van Weeren P.R., Perona G., Fleurance G., Robert C., Leger S., et al. Early changes in biomarkers of skeletal metabolism and their association to the occurrence of osteochondrosis (OC) in the horse. Equine Vet J 40 (2008) 253-259
25. de Grauw J.C., van de Lest C.H., van Weeren R., Brommer H., and Brama P.A. Arthrogenic lameness of the fetlock: synovial fluid markers of inflammation and cartilage turnover in relation to clinical joint pain. Equine Vet J 38 (2006) 305-311
26. Hollander A.P., Pidoux I., Reiner A., Rorabeck C., Bourne R., and Poole A.R. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 96 (1995) 2859-2869
27. Gallyas F., and Merchenthaler I. Copper-H2O2 oxidation strikingly improves silver intensification of the nickel-diaminobenzidine (Ni-DAB) end-product of the peroxidase reaction. J Histochem Cytochem 36 (1988) 807-810
28. Konttinen Y.T., Mandelin J., Li T.F., Salo J., Lassus J., Liljestrom M., et al. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum 46 (2002) 953-960
29. Squires G.R., Okouneff S., Ionescu M., and Poole A.R. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 48 (2003) 1261-1270
30. Werb Z., and Alexander C.M. Proteinases and matrix degradation. In: Sledge C.B., Rudoly S., Harris E.D., and Kelley W.N. (Eds). Arthritis and Surgery (1994), W.B.Saunders Company, Philadelphia 102-122
31. Hou W.S., Li Z., Gordon R.E., Chan K., Klein M.J., Levy R., et al. Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation. Am J Pathol 159 (2001) 2167-2177
32. Hou W.S., Li Z., Buttner F.H., Bartnik E., and Bromme D. Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation. Biol Chem 384 (2003) 891-897
33. Li Z., Hou W.S., and Bromme D. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 39 (2000) 529-536
34. Sondergaard B.C., Henriksen K., Wulf H., Oestergaard S., Schurigt U., Brauer R., et al. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis Cartilage 14 (2006) 738-748
35. Gray A.W., Davies M.E., and Jeffcott L.B. Localisation and activity of cathepsins K and B in equine osteoclasts. Res Vet Sci 72 (2002) 95-103
36. Grant M.E. From collagen chemistry towards cell therapy - a personal journey. Int J Exp Pathol 88 (2007) 203-214
37. Yasuda T., Tchetina E., Ohsawa K., Roughley P.J., Wu W., Mousa A., et al. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage. Matrix Biol 25 (2006) 419-429